The Cell Therapy Unit is a complex and sophisticated Good Manufacturing Practice (GMP) Unit for the manufacture of human cell and gene-based therapies.
It has the capacity to produce more than six final products simultaneously and the potential for production of around 1,000 therapies annually.
It is built to the exacting standards required to meet the licensing requirements of the MHRA (Medicines and Healthcare products Regulatory Agency), HRA (Health Research Authority) and JACIE (Joint Accreditation Committee of the International Society for Cellular Therapy and the European Group for Blood and Marrow Transplantation).
This GMP facility with three process suites contains:
- Grade B suite with closed processing in 1 Grade A isolator: Hepatocytes and Islets cell isolation
- Grade D suite with closed processing in 3 Grade A isolators: Cell Therapy (BMT & MSC)
- Grade D suite with closed processing in 2 Grade A isolators: Cell & Gene Therapy
- Additional controlled rate freezer room for cell freezing
- Controlled non-classified area comprising cryostore (sited on Ground floor), cold pack, prep and waste treatment
Common area & sample handling (outside CTU):
- QC lab
- Changing rooms
- Meeting room
- Write up room/hot desk area
- Staff refreshment room
- GMP Storage Facility
Key contacts:
CTU Director: Professor Anil Dhawan
CTU Quality Director: Penny Bligh
Facility Manager: Jonathan Foster
Senior Lab Technician: Laura Tolley
Lab Technician: Whitney Davies Mesh
Please contact us if you have a particular query and we can advise on who best to speak to.